Department of Urology, Warren Alpert School of Medicine, Brown University, Providence, RI, USA.
BJU Int. 2010 Aug;106(4):524-6. doi: 10.1111/j.1464-410X.2009.09091.x. Epub 2009 Dec 11.
To determine the prevalence of and risk factors for female sexual dysfunction (FSD) in a practice focused mainly on female urology.
A modified version of the Female Sexual Function Index (FSFI) was used to assess the prevalence of FSD in 587 patients who completed the questionnaire. Logistic regression was used to identify risk factors.
The prevalence of FSD was 63%; age, menopausal status and usage of selective serotonin reuptake inhibitors were statistically significant risk factors for FSD.
FSD is highly prevalent in this population of patients and screening female urological patients for FSD should be considered.
在一个主要关注女性泌尿外科的实践中，确定女性性功能障碍（FSD）的患病率和危险因素。
使用改良版女性性功能指数（FSFI）对完成问卷的 587 名患者评估 FSD 的患病率。使用逻辑回归识别危险因素。
FSD 的患病率为 63%；年龄、绝经状态和选择性 5-羟色胺再摄取抑制剂的使用是 FSD 的统计学显著危险因素。
在该患者人群中，FSD 的患病率很高，应考虑对女性泌尿外科患者进行 FSD 筛查。
